112 related articles for article (PubMed ID: 8239057)
1. A botanical compound, Padma 28, increases walking distance in stable intermittent claudication.
Drabaek H; Mehlsen J; Himmelstrup H; Winther K
Angiology; 1993 Nov; 44(11):863-7. PubMed ID: 8239057
[TBL] [Abstract][Full Text] [Related]
2. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
[TBL] [Abstract][Full Text] [Related]
3. Padma 28 for intermittent claudication.
Morling JR; Maxwell H; Stewart M
Cochrane Database Syst Rev; 2013 Jul; (7):CD007371. PubMed ID: 23861015
[TBL] [Abstract][Full Text] [Related]
4. Effects of vacusac in intermittent claudication: a controlled cross-over study.
Himmelstrup H; Himmelstrup B; Mehlsen J; Trap-Jensen J
Clin Physiol; 1991 May; 11(3):263-9. PubMed ID: 1893683
[TBL] [Abstract][Full Text] [Related]
5. Padma 28 for intermittent claudication.
Stewart M; Morling JR; Maxwell H
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007371. PubMed ID: 27021597
[TBL] [Abstract][Full Text] [Related]
6. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
7. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
Delis KT; Nicolaides AN; Wolfe JH; Stansby G
J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
[TBL] [Abstract][Full Text] [Related]
8. [Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication].
Schräder R; Nachbur B; Mahler F
Schweiz Med Wochenschr; 1985 Jun; 115(22):752-6. PubMed ID: 3892663
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of policosanol in the treatment of intermittent claudication.
Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
[TBL] [Abstract][Full Text] [Related]
10. Effects of naftidrofuryl in patients with intermittent claudication.
Karnik R; Valentin A; Stöllberger C; Slany J
Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy.
Circulation; 1989 Dec; 80(6):1544-8. PubMed ID: 2688971
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
[TBL] [Abstract][Full Text] [Related]
16. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
[TBL] [Abstract][Full Text] [Related]
18. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
[TBL] [Abstract][Full Text] [Related]
19. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
20. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
Kieffer E; Bahnini A; Mouren X; Gamand S
Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
